MedTech translation: from Research to Manufacturing
Medical technologies play an ever-increasing role in healthcare, with the potential to address numerous unmet clinical needs. With a complex pathway from idea to commercialisation, how can researchers and product developers ensure that their product meets clinical needs, and regulatory approval requirements? This webinar will explore how projects can improve their chances of translation into successful products, able to be used to improve patients’ lives. Join our expert panel as they bring perspectives from university, industry, and CSIRO in developing and commercialising MedTech products, with insights on the challenges and success factors from research to manufacturing.
This panel is proudly presented by the MedTech platform, Faculty of Engineering and Information Technology.
Refresh page and press play to start event. Please press 'unmute' on the event stream, and ensure volume is up high (bottom right blue bars). Should your stream appear blurry, you may increase and adjust the quality by navigating to the cogwheel on the bottom right of the video window, and select 720p or higher.
If you experience any technical difficulties, please chat to us via the box on the bottom right of this page. Otherwise, you may choose to watch the event via the alternative link here.
Meet the panelists
Professor Andrea O’Connor, Shanahan Chair in Frontier Medical Solutions, Department of Biomedical Engineering, The University of Melbourne (Chair)
Professor Andrea O’Connor, PhD, FIChemE is the Shanahan Chair in Frontier Medical Solutions and a Redmond Barry Distinguished Professor at the University of Melbourne and the Aikenhead Centre for Medical Discovery. She is a co-Director of the Victorian Medtech Skills and Device Hub and leads the Tissue Engineering Group in the Department of Biomedical Engineering. Her research focuses on design, synthesis and fabrication of biomaterials, porous materials and antimicrobial nanomaterials. She teaches biomedical engineering subjects including Tissue Engineering and Stem Cells. Prof. O’Connor collaborates with clinicians, scientists, hospitals, medical research institutes and medical device companies to address clinical problems.
_edited.png)
Mr Andrew Batty, Chief Executive Officer, Aikenhead Centre for Medical Discovery (ACMD)
Andrew is a MedTech executive with over 25 years of experience in healthcare, specializing in commercializing innovative technologies. He has held roles in Sales, Marketing, Business Development, Clinical Operations, and Management within pharmaceutical and biotech companies. Andrew has launched and managed companies like CogState, IM Medical, and Anatomics, establishing exits and global distribution channels. He is the founder and Director of Lincoln Consulting Group, assisting businesses in designing and implementing commercial strategies. Recently, he launched MedTech companies such as VividWhite, iFix Medical, and Morand Medical. Andrew holds a Bachelor of Science and a Master of Commerce, serves on several company boards, is the past chair of the University of Melbourne IAG for Biomedical Engineering, and is currently the interim CEO at the Aikenhead Centre for Medical Discovery.
%20(1)_edited.jpg)
A/Prof David Collins, Biomedical Engineering, The University of Melbourne
David is a Senior Lecturer in Biomedical Engineering at the University of Melbourne. His research focuses on developing systems for advanced bioprinting using novel micromanipulation methods, spanning from single-cell environments to macro-scale structures. He has expertise in integrated actuation methods in microfluidic systems, with applications for patterning and sorting microspecimens. David collaborates across four continents, working on projects such as 3D bioprinting to engineer single-cell microenvironments, bioprocess engineering for high-throughput micro-scale separations, and disease-on-a-chip models like blood-brain barrier systems for studying neurodegenerative disorders. Visit www.davidjohncollins.com for more information.
Dr Tim Hughes, CSIRO
Dr Timothy Hughes is a Senior Principal Research Scientist and Team Leader (Biomedical Polymers) at CSIRO. His work focuses on the design and synthesis of polymeric materials designed for specific biomedical applications. In particular, Dr Hughes’ expertise is in the field of polymeric biomaterials (hydrogels, fluoropolymers, polysiloxanes, biopolymers), 3D printing, medical devices, nanomaterial hybrids, and various self-assembly systems. He completed his PhD in synthetic organic chemistry at Monash University in 1997. He has successfully led a series of commercially focused industrial projects as well as a number of student projects covering a wide range of areas including ocular devices, surgical/tissue adhesives, drug delivery systems, cell therapies (cell encapsulation devices), medical imaging contrast agents and polymer 3D printing to deliver scientific impacts and commercial outcomes. His team works closely with companies within the biomedical industry to solve real world problems. He has published over 60 journal papers, and is co-inventor on 22 patents. He has been co-awarded several accolades for his work including the 2004 Eureka Award for Interdisciplinary Research and the 2009 and 2012 CSIRO Medals for Research Achievement.
If you have any queries about this event please contact the events team at industry-events@unimelb.edu.au
If you’d like to find out more about our work in engineering, technology, medicine and science please click here.